Could a gentle brain zap restore sensation after chemotherapy?

NCT ID NCT07673614

First seen Jun 29, 2026 · Last updated Jul 17, 2026 · Updated 4 times

Summary

This trial tests whether a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) can help cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN). CIPN causes numbness, tingling, pain, and movement problems. The study compares active tDCS to a sham (fake) procedure in 50 cancer survivors who are no longer on active treatment. Researchers measure changes in vibration and cold detection, balance, and walking ability right after stimulation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS)
What this could lead to
If effective, tDCS could offer a non-drug way to ease nerve pain and improve movement in cancer survivors with lasting chemotherapy side effects.
What could go wrong
This is a small, early-stage trial with 50 people. The effects are temporary, and it may not work for everyone or lead to a lasting treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.